
Keywords: DOX, doxorubicin; MM, multiple myeloma; UPS, ubiquitin-proteasome system; ANT, anthracyclin; ROS, reactive oxygen species; SP, standard proteasome; IP, immunoproteasome; PI, proteasome inhibitor; CM, cardiomyocyte; ABP, activity-based probeProteasome; Sub